QCOM
56
5
VIX
58
-13
HON
58
3
HOG
44
2
LNC
58
8
ILMN
28
-2
GOOGL
45
2
KMB
48
-2
HCA
57
6
MHK
42
-6
ECL
49
4
CAT
48
2
MLM
54
3
HRL
44
3
PYPL
33
8
AFL
59
4
CINF
45
4
COP
48
3
GOOG
55
2
MSI
43
2
QCOM
56
5
VIX
58
-13
HON
58
3
HOG
44
2
LNC
58
8
ILMN
28
-2
GOOGL
45
2
KMB
48
-2
HCA
57
6
MHK
42
-6
ECL
49
4
CAT
48
2
MLM
54
3
HRL
44
3
PYPL
33
8
AFL
59
4
CINF
45
4
COP
48
3
GOOG
55
2
MSI
43
2
Financhill
Back

West Pharmaceutical Services 10K Form

Sell
31

WST
West Pharmaceutical Services

Last Price:
$230.05
Seasonality Move:
8.24%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-04-25 10Q WST/West Pharmaceutical Services Quarterly
2023-10-26 10Q WST/West Pharmaceutical Services Quarterly
2023-07-27 10Q WST/West Pharmaceutical Services Quarterly
2023-04-27 10Q WST/West Pharmaceutical Services Quarterly
2022-10-27 10Q WST/West Pharmaceutical Services Quarterly
2022-07-28 10Q WST/West Pharmaceutical Services Quarterly

Receive WST News And Ratings

See the #1 stock for the next 7 days that we like better than WST

WST Financial Statistics

Sales & Book Value

Annual Sales: $2.9B
Cash Flow: $85.2M
Price / Cash Flow: 59.66
Annual Sales: $37.10
Price / Book: 6.03

Profitability

EPS (TTM): 6.69000
Net Income (TTM): $492.7M
Gross Margin: $998.5M
Return on Equity: 18.15%
Return on Assets: 13.51%

West Pharmaceutical Services Earnings Forecast

Key West Pharmaceutical Services Financial Ratios

  • The Gross Profit Margin over the past 41 years for WST is 34.51%.
  • The Selling, General & Administrative Expenses for WST have been equal to 11.70% of Gross Profit Margin.
  • The Research & Development expenses have been 2.39% of Revenue.
  • The Interest Expense is 0.61% of Operating Income.
  • The Net Earning history of WST is 17.03% of Total Revenues.
  • Per Share Earnings over the last 41 years have been positive in 27 years.

West Pharmaceutical Services Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: WST
CUSIP: 955306
Website: westpharma.com

Debt

Debt-to-Equity Ratio: 0.08
Current Ratio: 2.79
Quick Ratio: 1.88

Price-to-Earnings

Trailing P/E Ratio: 33.44
Forward P/E Ratio: 31.84

WST Technical Analysis vs Fundamental Analysis

Sell
31
West Pharmaceutical Services (WST) is a Sell

Is West Pharmaceutical Services a Buy or a Sell?